CD8A and neoplasm: Particularly in the context of tumorigenesis, the available CBL-B-null model has not been suitable for in vivo studies to assess the tumor cell-intrinsic roles of CBL proteins since CBL-B-null mice reject tumors due to their activated CD8+ T-cells [5, 23] and NK cells [24].